首页> 外文期刊>Molecular Neurobiology >Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System
【24h】

Derivation, Expansion, and Motor Neuron Differentiation of Human-Induced Pluripotent Stem Cells with Non-Integrating Episomal Vectors and a Defined Xenogeneic-free Culture System

机译:人诱导的多能干细胞的非整合附加型载体和定义的无异源培养系统的派生,扩展和运动神经元分化。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Induced pluripotent stem cells (iPSCs) generated from patient-derived somatic cells provides the opportunity for model development in order to study patient-specific disease states with the potential for drug discovery. However, use of lentivirus and exposure of iPSCs to animal-derived products limit their therapeutic utility and affect lineage differentiation and subsequent downstream functionality of iPSC derivatives. Within the context of this study, we describe a simple and practical protocol enabling the efficient reprogramming of terminally differentiated adult fibroblasts into integration-free human iPSCs (hiPSCs) using a combination of episomal plasmids with small molecules (SMs). Using this approach, there was a 10-fold increase in reprogramming efficiency over single plasmid vector-based methods. We obtained approximately 100 iPSCs colonies from 1 x 10(5) human adult dermal fibroblasts (HADFs) and achieved approximately 0.1 % reprogramming efficiencies. Concurrently, we developed a highly conducive culture system using xeno-free media and human vitronectin. The resulting hiPSCs were free of DNA integration and had completely lost episomal vectors, maintained long-term self-renewal, featured a normal karyotype, expressed pluripotent stem cell markers, and possessed the capability of differentiating into components of all three germ layers in vivo. Finally, we demonstrate that the integration-free hiPSCs could be differentiated into motor neurons under xeno-free culture conditions. This induction method will promote the derivation of patient-specific integration-free and xeno-free iPSCs and improve the strategy for motor neuron derivation. Our approach provides a useful tool for human disease models, drug screen, and clinical applications.
机译:由患者来源的体细胞产生的诱导性多能干细胞(iPSC)为模型开发提供了机会,以便研究具有药物发现潜力的患者特异性疾病状态。但是,慢病毒的使用以及iPSC与动物衍生产品的接触会限制其治疗效用,并影响谱系分化和iPSC衍生物的下游功能。在这项研究的背景下,我们描述了一个简单而实用的协议,能够使用游离质粒与小分子(SM)的组合,将最终分化的成年成纤维细胞有效地重编程为无整合的人iPSC(hiPSC)。使用这种方法,与基于单个质粒载体的方法相比,重编程效率提高了10倍。我们从1 x 10(5)人成年真皮成纤维细胞(HADF)获得了约100个iPSC菌落,并实现了约0.1%的重编程效率。同时,我们开发了使用无异种培养基和人玻连蛋白的高效培养系统。产生的hiPSCs没有DNA整合,完全失去了附加型载体,保持了长期自我更新,具有正常的核型,表达了多能干细胞标记,并具有在体内分化为所有三个细菌层的成分的能力。最后,我们证明了在无异种培养条件下,无整合的hiPSCs可以分化为运动神经元。这种诱导方法将促进患者特异性无整合和无异种iPSC的衍生,并改善运动神经元衍生的策略。我们的方法为人类疾病模型,药物筛选和临床应用提供了有用的工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号